Literature DB >> 11181822

Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique.

D D Allen1, Q R Smith.   

Abstract

Choline enters brain by saturable transport at the blood-brain barrier (BBB). In separate studies, both sodium-dependent and passive choline transport systems of differing affinity have been reported at brain capillary endothelial cells. In the present study, we re-examined brain choline uptake using the in situ rat brain perfusion technique. Saturable brain choline uptake from perfusion fluid was best described by a model with a single transporter (V:(max) = 2.4-3.1 nmol/min/g; K(m) = 39-42 microM) with an apparent affinity (1/Km)) for choline five to ten-fold greater than previously reported in vivo, but less than neuronal 'high-affinity' brain choline transport (K(m) = 1-5 microM). BBB choline uptake from a sodium-free perfusion fluid using sucrose for osmotic balance was 50% greater than in the presence of sodium suggesting that sodium is not required for transport. Hemicholinium-3 inhibited brain choline uptake with a K(i) (57 +/- 11 microM) greater than that at the neuronal choline system. In summary, BBB choline transport occurs with greater affinity than previously reported, but does not match the properties of the neuronal choline transporter. The V:(max) of this system is appreciable and may provide a mechanism for delivering cationic drugs to brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181822     DOI: 10.1046/j.1471-4159.2001.00093.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

2.  Nicotine exposure does not alter plasma to brain choline transfer.

Authors:  Paul R Lockman; Julie Gaasch; Ghia McAfee; Thomas J Abbruscato; Cornelis J Van der Schyf; David D Allen
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 3.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

4.  A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System.

Authors:  Di Wu; Meng Qin; Duo Xu; Lan Wang; Chaoyong Liu; Jie Ren; George Zhou; Chen Chen; Fengmei Yang; Yanyan Li; Yuan Zhao; Ruyi Huang; Sina Pourtaheri; Chunsheng Kang; Masakazu Kamata; Irvin S Y Chen; Zhanlong He; Jing Wen; Wei Chen; Yunfeng Lu
Journal:  Adv Mater       Date:  2019-02-25       Impact factor: 30.849

5.  Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Authors:  Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2007-07-21       Impact factor: 5.858

Review 6.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

7.  Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.

Authors:  Li Li; Sagar Agarwal; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2013-01-07       Impact factor: 3.922

8.  Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Vamshi K Manda; Rajendar K Mittapalli; Cornelis J Van der Schyf; Peter A Crooks; Linda P Dwoskin; David D Allen; Paul R Lockman
Journal:  Bioorg Med Chem Lett       Date:  2009-12-28       Impact factor: 2.823

9.  Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.

Authors:  Nicolas Spaeth; Matthias T Wyss; Jens Pahnke; Gregoire Biollaz; Amelie Lutz; Kerstin Goepfert; Gerrit Westera; Valerie Treyer; Bruno Weber; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-15       Impact factor: 9.236

10.  bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.

Authors:  Zhenfa Zhang; Paul R Lockman; Rajendar K Mittapalli; David D Allen; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2008-08-30       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.